Spelling suggestions: "subject:"glycans"" "subject:"nglycans""
1 |
Studies on the expression, purification, and synthetic utility of recombinant yeast #beta#-1,4-mannosyltransferaseRevers, Leigh January 1996 (has links)
No description available.
|
2 |
Functional and structural insights into Glycoside Hydrolase family 130 enzymes : implications in carbohydrate foraging by human gut bacteria / Apports fonctionnels et structuraux à la famille des glycoside hydrolase 130 : implications dans la dégradation des glycanes par les bactéries de l'intestin humainLadevèze, Simon 28 April 2015 (has links)
Les relations entre bactéries intestinales, aliments et hôte jouent un rôle crucial dans lemaintien de la santé humaine. La caractérisation fonctionnelle d’Uhgb_MP, une enzyme dela famille 130 des glycoside hydrolases découverte par métagénomique fonctionnelle, arévélé une nouvelle fonction de dégradation par phosphorolyse des polysaccharides de laparoi végétale et des glycanes de l'hôte tapissant l'épithélium intestinal. Les déterminantsmoléculaires de la spécificité d’Uhgb_MP vis-à-vis des mannosides ont été identifiés grâce àla résolution de sa structure cristallographique, sous forme apo et en complexe avec sesligands. Un nouveau procédé de synthèse par phosphorolyse inverse d'oligosaccharidesmannosylés à haute valeur ajoutée, a aussi été développé. Enfin, la caractérisationfonctionnelle de la protéine BACOVA_03624 issue de Bacteroides ovatus ATCC 8483, unebactérie intestinale hautement prévalente, a révélé que la famille GH130 comprend à la foisdes glycoside-hydrolases et des glycoside-phosphorylases capables de dégrader lesmannosides et les galactosides, et de les synthétiser par phosphorolyse inverse et/outransglycosylation. L’ensemble de ces résultats, ainsi que l’identification d’inhibiteurs desenzymes de la famille GH130, ouvrent de nouvelles perspectives pour l'étude et le contrôledes interactions microbiote-hôte / The interplay between gut bacteria, food and host play a key role in human health. Thefunctional characterization of Uhgb_MP, an enzyme belonging to the family 130 of glycosidehydrolases, discovered by functional metagenomics, revealed novel functions of plant cellwall polysaccharide and host glycan degradation by phosphorolysis. The moleculardeterminants of Uhgb_MP specificity towards mannosides were identified by solving itscrystal structure, in apo form and in complex with its ligands. A new process of high addedvalue mannosylated oligosaccharide synthesis by reverse-phosphorolysis was alsodeveloped. Finally, the functional characterization of the BACOVA_03624 protein fromBacteroides ovatus ATCC 8483, a highly prevalent gut bacterium, revealed that GH130 familyboth contains glycoside phosphorylases and glycoside hydrolases, which are able to degrademannosides and galactosides, and to synthesize them by reverse-phosphorolysis and/ortransglycosylation. All these results, together with the identification of GH130 enzymeinhibitors, open new perspectives for studying, and potentially also for controlling,interactions between host and gut microbes
|
3 |
MICROBIAL GLYCOSIDE HYDROLASE MEDIATED MODIFICATION OF HOST CELL SURFACE GLYCANSPasupathi, Aarthi January 2023 (has links)
All cells and extracellular matrices of prokaryotes and eukaryotes are made up of glycans, the carbohydrate macromolecules that play a predominant role in cell-to-cell interaction, protection, stabilization, and barrier functions. Glycans are also central to human microbiome-host interactions where bacterial glycans are recognized by innate immune signaling pathways, and host mucins are a major nutrient source for various gut bacteria. Many microorganisms encode glycoside hydrolases (GHs) to utilize the available host cell surface glycans as a nutrient source and to modulate host protein function. The GHs are divided into families having conserved linkage specificity within each family and individual family members can be specific for dramatically divergent macromolecular substrates. In general, within a given GH family very few members have been biochemically characterized and the substrate specificity is poorly understood. GH genes are abundant in the human gut microbiome and culture-enriched metagenomics identified more than 10,000 distinct bacterial GH genes in an individual. The focus of this thesis is endo-β-N-acetylglucosaminidases (ENGases) encoded by GH18 and GH85 families. Bioinformatic analysis shows that the predicted proteins within each of these GH families fell into separate clusters in the Sequence Similarity Networks of each family. The hypothesis of this project is that human microbiome-encoded ENGases from the same GH family differ in their substrate specificities and within the SSN network of the same GH family, enzymes with similar substrate specificity may fall in the same cluster. In this work, I established conditions for overexpression of GH18 and GH85 proteins and investigated the activity of these enzymes on various substrates. / Thesis / Master of Science (MSc) / All the cell surfaces of animals, plants, and microbes are coated with sugars, also known as glycans. These sugars on the cell surface act as a barrier and protect them from the external environment. Glycans on the cells of both microbes and humans are essential for basic interactions between them. Many bacteria produce enzymes such as glycoside hydrolases to obtain nutrients from dietary sugars and alter the sugars on host proteins. There are various families of these enzymes, and they act on specific sugars and cleavage sites. The substrate specificities and characterization of these enzymes from most bacteria found in the human microbiome have not been studied in detail. My work focuses on developing standard enzyme assays for determining specific substrate specificities. This tool can be used to reshape glycans and understand their role in cell processes.
|
4 |
Analysis of Folate Binding Protein and Associated N-Glycans by Mass Spectrometry and Light MicroscopyJaiswal, Nidhi 17 May 2011 (has links)
No description available.
|
5 |
Caracterização da estrutura oligossacarídica de prolactina glicosilada humana (G-hPRL) nativa e recombinante / Characterization of the oligosaccharide structure of human glycosylated prolactin (G-hPRL) native and recombinantCapone, Marcos Vinicius Nucci 26 April 2013 (has links)
A prolactina humana (hPRL) é um hormônio polipeptídico secretado pela hipófise anterior sob regulação do hipotálamo, envolvido em uma variedade de processos biológicos como o desenvolvimento da glândula mamária e lactação. O produto recombinante é importante no diagnóstico médico e no tratamento de insuficiência da lactação. Este hormônio pode ocorrer sob a forma de proteína não glicosilada (NG-hPRL) e glicosilada (G-hPRL), com pesos moleculares de aproximadamente 23 e 25 kilodalton (kDa), respectivamente; possui um único sítio de N-glicosilação localizado na asparagina (Asn) posição 31, que é parcialmente ocupado, representando assim um modelo particularmente interessante de glicosilação. A atividade biológica da G-hPRL é muito menor comparada à NG-hPRL (~4 vezes) e sua função fisiológica ainda não é bem definida: a porção de carboidrato parece ter um importante papel na biossíntese, secreção, atividade biológica, e sobrevivência plasmática do hormônio. O objetivo principal desse trabalho foi comparar as estruturas dos N-glicanos presentes na prolactina glicosilada hipofisária (G-hPRL-NHPP) com a recombinante. Para obter a G-hPRL recombinante foi realizada uma produção em escala laboratorial a partir de células de ovário de hamster chinês (CHO) geneticamente modificadas e adaptadas ao crescimento em suspensão. Foi adicionada, ao meio de cultura cicloheximida (CHX), cujo efeito principal foi aumentar a relação G-hPRL/NGhPRL que passou de 5% para 38%, facilitando assim a purificação da G-hPRL. A G-hPRL foi purificada em duas etapas, uma troca catiônica seguida de purificação por cromatografia liquida de alta eficiência de fase reversa (RP-HPLC) que se demonstrou eficiente na separação das duas isoformas de hPRL. A G-hPRL recombinante IPEN foi assim analisada por diversas técnicas confirmando a sua pureza e atividade biológica, incluindo comparações com outras amostras de referências de origem hipofisária adquirida junto ao National Hormone & Peptide Program (NHPP-E.U.A.) . Foi realizada também a determinação inédita de Nglicanos presentes na G-hPRL produzida por células CHO e na G-hPRL nativa, produzida pela hipófise humana, possibilitando comparar as duas estruturas de carboidratos e alcançando assim uma das principais metas desse projeto. Entre as principais diferenças encontradas nas estruturas dos dois N-glicanos, destacam-se a baixa quantidade de ácido siálico (NeuAc), a alta porcentagem de glicanos sulfatos (74,0%) e com fucose (Fuc) (93,3%) presentes na amostra hipofisária e a tendência da preparação recombinante de apresentar glicanos com maior peso molecular e com uma menor variação nas isoformas. / Human prolactin (hPRL) is a polypeptide hormone secreted by the anterior pituitary under the regulation of the hypothalamus, involved in a variety of biological processes such as mammary gland development and lactation. The recombinant product is important in medical diagnosis and treatment of failure of lactation. This hormone may occur in the form of non-glycosylated protein (NGhPRL) and glycosylated (G-hPRL) with molecular weights of approximately 23 and 25 kilodalton (kDa), respectively; has a single N-glycosylation site located at asparagine (Asn) position 31, which is partially occupied, thus being a particularly interesting model of glycosylation. The biological activity of G-hPRL is lower compared to NG-hPRL (~4 times) and its physiological function is not well defined: the portion of carbohydrate appears to have an important role in the hormone biosynthesis, secretion, biological activity, and plasma survival of the hormone. The main objective of this study was to compare the structures of N-glycans present in glycosylated pituitary prolactin (G-hPRL-NHPP) with those present in the recombinant. To obtain the recombinant G-hPRL the production was performed in laboratory scale from Chinese hamster ovary cells (CHO), genetically modified and adapted to growth in suspension. Cycloheximide (CHX), whose main effect was to increase the ratio G-hPRL/NG-hPRL from 5% to 38% was added to the culture medium, thereby facilitating the purification of G-hPRL. The G-hPRL was purified in two steps, a cation exchanger followed by a purification by reversed-phase high performance liquid chromatography (RP-HPLC) which demonstrated the efficient separation of the two isoforms of hPRL. Recombinant G-hPRL-IPEN was well characterized by several techniques confirming its purity and biological activity, including comparisons with other reference preparation of pituitary origin purchased from the \"National Hormone & Peptide Program (NHPPU. S.)\". The composition of N-glycans present in the G-hPRL, produced by CHO cells, and that of native G-hPRL, produced by the human pituitary gland, were also determined for the first time, allowing the two structures of carbohydrates to be compared and thus, achieving one of the main goals of this project. Among the main differences in N-glycan structures, we highlight the low presence of sialic acid (NeuAc) and the high percentage of sulfated glycans (74.0%) and of fucose (Fuc) (93.3%) in the pituitary sample and the tendency of the recombinant preparation to present glycans with higher molecular weight and less isoforms variation.
|
6 |
Caracterização da estrutura oligossacarídica de prolactina glicosilada humana (G-hPRL) nativa e recombinante / Characterization of the oligosaccharide structure of human glycosylated prolactin (G-hPRL) native and recombinantMarcos Vinicius Nucci Capone 26 April 2013 (has links)
A prolactina humana (hPRL) é um hormônio polipeptídico secretado pela hipófise anterior sob regulação do hipotálamo, envolvido em uma variedade de processos biológicos como o desenvolvimento da glândula mamária e lactação. O produto recombinante é importante no diagnóstico médico e no tratamento de insuficiência da lactação. Este hormônio pode ocorrer sob a forma de proteína não glicosilada (NG-hPRL) e glicosilada (G-hPRL), com pesos moleculares de aproximadamente 23 e 25 kilodalton (kDa), respectivamente; possui um único sítio de N-glicosilação localizado na asparagina (Asn) posição 31, que é parcialmente ocupado, representando assim um modelo particularmente interessante de glicosilação. A atividade biológica da G-hPRL é muito menor comparada à NG-hPRL (~4 vezes) e sua função fisiológica ainda não é bem definida: a porção de carboidrato parece ter um importante papel na biossíntese, secreção, atividade biológica, e sobrevivência plasmática do hormônio. O objetivo principal desse trabalho foi comparar as estruturas dos N-glicanos presentes na prolactina glicosilada hipofisária (G-hPRL-NHPP) com a recombinante. Para obter a G-hPRL recombinante foi realizada uma produção em escala laboratorial a partir de células de ovário de hamster chinês (CHO) geneticamente modificadas e adaptadas ao crescimento em suspensão. Foi adicionada, ao meio de cultura cicloheximida (CHX), cujo efeito principal foi aumentar a relação G-hPRL/NGhPRL que passou de 5% para 38%, facilitando assim a purificação da G-hPRL. A G-hPRL foi purificada em duas etapas, uma troca catiônica seguida de purificação por cromatografia liquida de alta eficiência de fase reversa (RP-HPLC) que se demonstrou eficiente na separação das duas isoformas de hPRL. A G-hPRL recombinante IPEN foi assim analisada por diversas técnicas confirmando a sua pureza e atividade biológica, incluindo comparações com outras amostras de referências de origem hipofisária adquirida junto ao National Hormone & Peptide Program (NHPP-E.U.A.) . Foi realizada também a determinação inédita de Nglicanos presentes na G-hPRL produzida por células CHO e na G-hPRL nativa, produzida pela hipófise humana, possibilitando comparar as duas estruturas de carboidratos e alcançando assim uma das principais metas desse projeto. Entre as principais diferenças encontradas nas estruturas dos dois N-glicanos, destacam-se a baixa quantidade de ácido siálico (NeuAc), a alta porcentagem de glicanos sulfatos (74,0%) e com fucose (Fuc) (93,3%) presentes na amostra hipofisária e a tendência da preparação recombinante de apresentar glicanos com maior peso molecular e com uma menor variação nas isoformas. / Human prolactin (hPRL) is a polypeptide hormone secreted by the anterior pituitary under the regulation of the hypothalamus, involved in a variety of biological processes such as mammary gland development and lactation. The recombinant product is important in medical diagnosis and treatment of failure of lactation. This hormone may occur in the form of non-glycosylated protein (NGhPRL) and glycosylated (G-hPRL) with molecular weights of approximately 23 and 25 kilodalton (kDa), respectively; has a single N-glycosylation site located at asparagine (Asn) position 31, which is partially occupied, thus being a particularly interesting model of glycosylation. The biological activity of G-hPRL is lower compared to NG-hPRL (~4 times) and its physiological function is not well defined: the portion of carbohydrate appears to have an important role in the hormone biosynthesis, secretion, biological activity, and plasma survival of the hormone. The main objective of this study was to compare the structures of N-glycans present in glycosylated pituitary prolactin (G-hPRL-NHPP) with those present in the recombinant. To obtain the recombinant G-hPRL the production was performed in laboratory scale from Chinese hamster ovary cells (CHO), genetically modified and adapted to growth in suspension. Cycloheximide (CHX), whose main effect was to increase the ratio G-hPRL/NG-hPRL from 5% to 38% was added to the culture medium, thereby facilitating the purification of G-hPRL. The G-hPRL was purified in two steps, a cation exchanger followed by a purification by reversed-phase high performance liquid chromatography (RP-HPLC) which demonstrated the efficient separation of the two isoforms of hPRL. Recombinant G-hPRL-IPEN was well characterized by several techniques confirming its purity and biological activity, including comparisons with other reference preparation of pituitary origin purchased from the \"National Hormone & Peptide Program (NHPPU. S.)\". The composition of N-glycans present in the G-hPRL, produced by CHO cells, and that of native G-hPRL, produced by the human pituitary gland, were also determined for the first time, allowing the two structures of carbohydrates to be compared and thus, achieving one of the main goals of this project. Among the main differences in N-glycan structures, we highlight the low presence of sialic acid (NeuAc) and the high percentage of sulfated glycans (74.0%) and of fucose (Fuc) (93.3%) in the pituitary sample and the tendency of the recombinant preparation to present glycans with higher molecular weight and less isoforms variation.
|
7 |
Etude structure-fonction d'une fucosyltransférase (FucTA) de Arabidopsis thaliana.Both, Peter 29 October 2009 (has links) (PDF)
Ce travail cherche à apporter un éclairage sur les relations séquence-structure-fonction des alpha1,3/4-fucosyltransférases, avec un accent particulier sur les core alpha1,3-fucosyltransférases des plantes. La fucosylation de type Core alpha1,3 est une caractéristique des oligosaccharides N-liés des plantes et invertébrés, avec une fonction biologique qui n'est pas encore élucidée. L'activité Core alpha1,3-fucosyltransférase est responsable d'allergies alimentaires, au pollen, et aux insectes chez l'homme. Dans le cadre de ce travail sont présentés des résultats de caractérisation biochimique (effet de cations divalents sur l'activité, Km de substrat donneur), des expériences de troncation des différents domaines (ex: suppression du domaine C-terminal spécifique aux core alpha1,3-fucosyltransférases des plantes), et de mutagenèse dirigée, en utilisant comme protéine modèle, la core 1,3-fucosyltransferase A (FucTA) d'Arabidopsis thaliana qui a été exprimée sous forme recombinante chez Pichia pastoris. Ces expériences ont été dictées sur la base de nos résultats d'analyses bioinformatiques des séquences de alpha1,3/4-fucosyltransférases et de la modélisation par homologie du domaine de liaison au nucléotide-sucre de l'enzyme FucTA. La mutagenèse des résidus clé identifiés par cette approche a permis de confirmer l'importance de certains acides aminés dans le mécanisme catalytique. Enfin la protéine FucTA étant elle-même glycosylée quand elle est produite chez P. pastoris, nous avons étudié l'impact de cette glycosylation sur la production et l'activité de la protéine, par des expériences de mutagenèse, de Western blotting et de spectrométrie de masse.
|
8 |
Utilisation du triflate de fer(III) en glycosylation sous activation micro-ondes ou en flux continu / Glycosylation promoted by iron triflate(III) under microwave irradiation or in continuous flowXolin, Amandine 06 November 2015 (has links)
Les oligosaccharides et les glycoconjugués jouent des rôles essentiels dans de nombreux processus biologiques. Cependant, leur synthèse est plus complexe que la majorité des autres biomolécules. Le principal défi réside souvent dans la formation de la liaison glycosidique. Il est donc toujours nécessaire de développer des réactions de glycosylation efficaces et totalement stéréosélectives, utilisant de nouveaux donneurs et permettant d'accéder à des structures glycosidiques à différentes échelles. Ces réactions sont d'autant plus intéressantes si elles utilisent des promoteurs peu chers, peu toxiques et peu dangereux pour l'environnement, comme des sels de fer. Dans ce cadre, la formation directe de b-glycosides de la N-acétyl-D-glucosamine par catalyse au triflate de fer(III) a été étudiée. Cette glycosylation peut être réalisée sous irradiation micro-ondes ou en flux continu. Les conditions d'activation sous micro-ondes ont ensuite été étendues à la synthèse de motifs de N-glycanes complexes. Cette synthèse consiste en une étape de polyglycosylation au triflate de fer(III), combinée à une étape d'introduction d'un lien moléculaire, via une nouvelle glycosylation ou une réaction de la chimie click. Enfin, une a-mannosylation utilisant le triflate de fer(III) a été découverte et mise au point. Cette glycosylation, réalisée sous activation micro-ondes, est totalement stéréosélective, même en l'absence de groupement participant. / Oligosaccharides and glycoconjugates are involved in numerous biological events. However, their synthesis is generally more complex than for other biomolecules. The main challenge is often the generation of the glycosidic bond. For this reason, it is still important to develop efficient and stereoselective glycosylations, which afford glycosides in significant amounts using new donors. These reactions are even more attractive if the promoter used is cheap, non-toxic and environmentally friendly, like iron salts. In this context, the direct synthesis of b-glycosides of N-acetyl-D-glucosamine using catalytic iron triflate(III) has been developed. This glycosylation can be performed under microwave irradiation or in continuous flow. The microwave-assisted conditions were then extended to the synthesis of complex N-glycan mimics. This synthesis is based on a polyglycosylation reaction using an iron(III) triflate catalysis coupled to another glycosylation or a click reaction to introduce a functionalized linker. Finally, an a-mannosylation promoted by iron(III) triflate has been developed. This glycosylation, performed under microwave irradiation, is completely stereoselective, even without neighbouring group participation.
|
9 |
Etude et ingénierie de la N-glycosylation des protéines chez la microalgue verte chlamydomanas reinhardtii. / Titre en anglais non communiquéLucas, Pierre-Louis 11 September 2019 (has links)
Actuellement, plus de 70% des biomédicaments commercialisés sont des glycoprotéines recombinantes. Les coûts élevés de production de ces biomédicaments ont poussé les scientifiques à développer des organismes de production alternatifs. Récemment, les microalgues ont été proposées en tant que potentiel système de production compte-tenu de leur rapidité de croissance et de leurs faibles coûts de production. Cependant, avant de produire des biomédicaments industriels chez les microalgues, il est impératif de s’assurer que les modifications post-traductionnelles, comme la N-glycosylation, soit conservées et compatibles avec une utilisation thérapeutique. Dans ce contexte, l’étude de la Nglycosylation de deux microalgues modèles, Chlamydomonas reinhardtii (microalgue verte) et Phaeodactylum tricornutum (diatomée) a été réalisée. Dans un premier temps, l’ingénierie de la N-glycosylation de C. reinhardtii a été initiée en exprimant une Nacétylglucosaminyltransférase I (GnT I) hétérologue. Les résultats obtenus ont permis de réévaluer les voies de N-glycosylation de C. reinhardtii et de montrer que cette microalgue synthétise une structure glycannique linéaire qui n’est pas substrat de la GnT I. Dans un second temps, un protocole d’extraction et de caractérisation des précurseurs glycanniques de C. reinhardtii et P. tricornutum a été développé et appliqué pour déterminer la structure des précurseurs glycanniques dans ces espèces. Enfin, la caractérisation de deuxxylosyltransférases potentielles (XTA et XTB) de C. reinhardtii a été menée en utilisant des mutants d’insertion et des analyses des N-glycannes par spectrométrie de masse. Cette étude a confirmé les rôles spécifiques de XTA et XTB dans la voie de N-glycosylation de C. reinhardtii. / Currently, more than 70% of the commercialized biopharmaceuticals are glycoproteins. The high production costs lead scientists to develop alternative organisms suitable for such production. Recently, microalgae emerged as a potential interesting production system thanks to their quick growth rate and low production costs. However, prior to start industrial glycoproteins production in microalgae, protein post-translational modifications like Nglycosylation, must be carefully controlled. This PhD thesis focused on the analysis of the Nglycosylation pathway of two different microalgae, Chlamydomonas reinhardtii (greenmicroalgae) and Phaeodactylum tricornutum (diatom). In order to start N-glycan engineering, heterologous N-acetylglucosaminyltransferase I (GnT I) sequences were expressed in C.reinhardtii. This study demonstrated that C. reinhardtii synthetize a linear N-glycan unsuitable for GnT I activity and allows the reinvestigation of the C. reinhardtii N-glycosylation pathway. A second chapter of this work focus on the optimization of a protocol suitable for analyzing the structure of the Dolichol N-linked precursors of C. reinhardtii and P. tricornutum. Lastly, two potential xylosyltransferases (XTA and XTB) from C. reinhardtii were characterized using insertional mutants and N-glycomic analyses by mass spectrometry approaches. This work allows us to propose specific involvement of XTA and XTB in the xylosylation processing of C.reinhardtii N-glycans.
|
10 |
Detection of changes in n-glycosylation profiles of therapeutic glycoproteins using LC-MSPlaninc, Ana 19 December 2016 (has links) (PDF)
Biopharmaceuticals are becoming one of the most promising drugs on the market mainly due to their successful treatment of a vast array of serious diseases, such as cancers, immune disorders, and infections. Structurally, biopharmaceuticals are proteins and it is important to mention that more than 60 % of biopharmaceuticals are glycosylated. Glycosylation is one of the most common posttranslational modifications. It is also the most demanding and the most complex posttranslational modification. The research showed that glycosylation can significantly impact on the safety, efficiency, and quality of the therapeutic glycoproteins. In the first part of the introduction of the present thesis, the development of the therapeutic glycoproteins and their classification were reviewed. Glycosylation process and nomenclature were also discussed. The second part of the introduction revealed current issues in the field of the production and the characterization of the therapeutic glycoproteins. In the context of the doctoral thesis, we introduced new approach, namely hydrophilic interaction liquid chromatography coupled to a high-resolution mass spectrometer (HILIC-HR-MS) combined with Principal Component Analysis (PCA) and classification through Soft Independent Modelling by Class Analogy (SIMCA) data treatment. Accordingly, N-glycans were first enzymatically released using peptide-N-glycosidase F (PNGase F) and reduced using sodium borohydride. Then those N-glycans were separated by HILIC and detected by HR-MS. PCA and SIMCA simplified interpretation of the MS data collected in the huge tables. PCA was applied to test whether it is possible to visualize N-glycosylation differences between samples and to help identifying within which N-glycans changes occurred. SIMCA, which is a more complex data analysis technique, was applied to build and validate a classification models. SIMCA was also applied to verify whether it is possible to use built models to classify real samples. Described approach enabled us to detect small changes in N-glycosylation of the therapeutic glycoproteins (a change of only 1% in relative glycan abundance). It was applied to assess changes in N-glycosylation of therapeutic glycoproteins. Accordingly, we tested N-glycosylation consistency between batches of infliximab, trastuzumab, and bevacizumab and monitored the N-glycosylation of bevacizumab over storage time in plastic syringes.Furthermore, we worked on the faster sample preparation technique, where online-solid-phase extraction (SPE)-LC was combined to the previously mentioned HILIC-MS-PCA/SIMCA method. Online-SPE-LC allowed us to faster the sample preparation in terms of avoiding time-consuming cleaning steps. / Doctorat en Sciences / info:eu-repo/semantics/nonPublished
|
Page generated in 0.0434 seconds